J. Goldman & Co’s Carter's CRI Stock Holding History

J. Goldman & Co’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-366,719	Closed	-$13.1M	–	745
2026 Q1	$13.1M	Buy	+366,719	New	+$13.3M	0.38%	73
2024 Q4	–	Sell	-15,025	Closed	-$976K	–	492
2024 Q3	$976K	Buy	+15,025	New	+$965K	0.03%	298

Other funds holding CRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RWWM Inc Rocklin, California $1.35B AUM 9.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

J. Goldman & Co's CRI Position: Q2 2026 in Review

J. Goldman & Co sold out of Carter's (CRI) in Q2 2026, closing a stake of 366,719 shares — an estimated $13.1M sold.

J. Goldman & Co first reported a position in CRI in Q3 2024 and held it in 2 quarters. The position peaked at $13.1M in Q1 2026. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

J. Goldman & Co reported no remaining Carter's position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 366,719 Carter's shares in Q2 2026, an estimated $13.1M.
J. Goldman & Co first reported a position in Carter's in Q3 2024 and held it in 2 quarters.
J. Goldman & Co's Carter's position peaked at $13.1M in Q1 2026.
287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.